Translational Medicine 2.0: From Clinical Diagnosis-Based to Molecular-Targeted Therapies in the Era of Globalization

被引:10
作者
Albani, S. [1 ,2 ]
Colomb, J. [1 ,2 ]
Prakken, B. [1 ,3 ]
机构
[1] Eureka Inst Translat Res, Siracusa, Italy
[2] Sanford Burnham Med Res Inst, Inflammatory & Infect Dis Ctr, La Jolla, CA USA
[3] Univ Med Ctr Utrecht, Ctr Mol & Cellular Intervent, Dept Pediat Immunol, Utrecht, Netherlands
关键词
CHALLENGES;
D O I
10.1038/clpt.2010.60
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Translational medicine encompasses the itinerary from the conception of an idea to its implementation in the diagnosis, prognosis, and treatment of human diseases. It cannot be identified as a stand-alone field; rather, it comprises a fragmented patchwork of activities, competencies, and knowledge distributed along diverse and often disparate disciplines. In standard practice, the success of a translational project is often less dependent on the validity of the original idea than on the outcome of the combination of several stochastic events.
引用
收藏
页码:642 / 645
页数:4
相关论文
共 9 条
[1]   The advancement of translational medicine-from regional challenges to global solutions [J].
Albani, Salvatore ;
Prakken, Berent .
NATURE MEDICINE, 2009, 15 (09) :1006-1009
[2]   Translational pharmacology: Harnessing increased specialization of research within the basic biological sciences [J].
Anger, G. J. ;
Piquette-Miller, M. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (06) :797-801
[3]   A powerful genome-wide feasible approach to detect parent-of-origin effects in studies of quantitative traits [J].
Belonogova, Nadezhda M. ;
Axenovich, Tatiana I. ;
Aulchenko, Yurii S. .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2010, 18 (03) :379-384
[4]  
Dankwa-Mullan I, AM J PUBLIC HLTH
[5]   Finding the right research question: Quality science depends on quality careers [J].
Flockhart, D. A. ;
Abernethy, D. R. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (03) :427-429
[6]   Development of translational pharmacokinetic-pharmacodynamic models [J].
Mager, D. E. ;
Jusko, W. J. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (06) :909-912
[7]   Central challenges facing the national clinical research enterprise [J].
Sung, NS ;
Crowley, WF ;
Genel, M ;
Salber, P ;
Sandy, L ;
Sherwood, LM ;
Johnson, SB ;
Catanese, V ;
Tilson, H ;
Getz, K ;
Larson, EL ;
Scheinberg, D ;
Reece, EA ;
Slavkin, H ;
Dobs, A ;
Grebb, J ;
Martinez, RA ;
Korn, A ;
Rimoin, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (10) :1278-1287
[8]   Pharmacoeconomics in the era of individualized medicine [J].
Waldman, S. A. ;
Terzic, A. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (02) :179-182
[9]  
Wyngaarden J B, 1979, Trans Assoc Am Physicians, V92, P1